U.S. Physical Therapy (NYSE:USPH) updated its FY 2019 earnings guidance on Thursday. The company provided EPS guidance of $2.76-2.85 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.80. The company issued revenue guidance of $35.1-36.4 million, compared to the consensus revenue estimate of $480.84 million.
A number of research analysts have recently commented on the stock. Zacks Investment Research downgraded shares of U.S. Physical Therapy from a buy rating to a hold rating in a research note on Saturday, February 9th. William Blair assumed coverage on U.S. Physical Therapy in a report on Thursday. They set an outperform rating and a $106.61 target price for the company. Finally, ValuEngine cut U.S. Physical Therapy from a strong-buy rating to a buy rating in a report on Wednesday. Five equities research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. U.S. Physical Therapy currently has an average rating of Hold and an average target price of $111.90.
Shares of NYSE:USPH opened at $108.80 on Friday. The company has a debt-to-equity ratio of 0.26, a current ratio of 1.93 and a quick ratio of 1.93. U.S. Physical Therapy has a 1 year low of $79.40 and a 1 year high of $129.65. The stock has a market cap of $1.38 billion, a PE ratio of 52.31, a PEG ratio of 3.62 and a beta of 1.14.
The company also recently announced a quarterly dividend, which will be paid on Friday, April 19th. Stockholders of record on Wednesday, March 20th will be issued a dividend of $0.27 per share. The ex-dividend date of this dividend is Tuesday, March 19th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.99%. This is a boost from U.S. Physical Therapy’s previous quarterly dividend of $0.23. U.S. Physical Therapy’s payout ratio is presently 44.23%.
In related news, Director Harry S. Chapman purchased 1,200 shares of the firm’s stock in a transaction on Tuesday, December 11th. The stock was purchased at an average price of $110.69 per share, for a total transaction of $132,828.00. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Regg E. Swanson purchased 500 shares of the firm’s stock in a transaction on Wednesday, December 26th. The stock was bought at an average price of $101.17 per share, with a total value of $50,585.00. The disclosure for this purchase can be found here. 2.50% of the stock is currently owned by insiders.
ILLEGAL ACTIVITY NOTICE: “U.S. Physical Therapy (USPH) Issues FY 2019 Earnings Guidance” was published by Ticker Report and is the property of of Ticker Report. If you are viewing this piece of content on another domain, it was illegally copied and reposted in violation of U.S. & international trademark & copyright law. The original version of this piece of content can be accessed at https://www.tickerreport.com/banking-finance/4209318/u-s-physical-therapy-usph-issues-fy-2019-earnings-guidance.html.
About U.S. Physical Therapy
U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
Recommended Story: Key terms to understand channel trading
Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.